α7 Nicotinic Receptor Agonists: Potential Therapeutic Drugs for Treatment of Cognitive Impairments in Schizophrenia and Alzheimer’s Disease

Accumulating evidence suggests that α7 nicotinic receptors (α7 nAChRs), a subtype of nAChRs, play a role in the pathophysiology of neuropsychiatric diseases, including schizophrenia and Alzheimer’s disease (AD). A number of psychopharmacological and genetic studies shown that α7 nAChRs play an impor...

Descripción completa

Detalles Bibliográficos
Autores principales: Toyohara, Jun, Hashimoto, Kenji
Formato: Texto
Lenguaje:English
Publicado: Bentham Open 2010
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3023065/
https://www.ncbi.nlm.nih.gov/pubmed/21249164
http://dx.doi.org/10.2174/1874104501004010037

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3023065/
https://www.ncbi.nlm.nih.gov/pubmed/21249164
http://dx.doi.org/10.2174/1874104501004010037

Ejemplares similares